Roche outlines plans for autonomous AI labs in R&D
Company says it is committed to "AI independence" in research and has started building autonomous AI-driven labs.
ZURICH, Sept 28 (Reuters) — Swiss pharmaceutical giant Roche outlined plans to move towards autonomous AI labs to speed up research and development discovery at its pharma investor day on Monday. Roche is committed to "AI independence" in R&D and has recently started building autonomous AI-driven labs, Aviv Regev, executive vice president of Genentech Research and Early Development, said. com)